China Pharma Holdings (CPHI) Other financing activities (2011 - 2012)
China Pharma Holdings' (CPHI) quarterly Other financing activities came in at $1.3 million in Q3 2012, down 73.96% on a YoY basis from $5.0 million in Q4 2011, and down 73.96% quarter-over-quarter from $5.0 million in Q3 2011.
Powered by 
Analysis
China Pharma Holdings (CPHI) Other financing activities (2011 - 2012) Analysis & Trends
China Pharma Holdings (CPHI) has reported Other financing activities for 2 consecutive years, with $1.3 million the latest figure, recorded in Q3 2012.
- For the quarter ending Q3 2012, Other financing activities fell 73.96% year-over-year to $1.3 million; the trailing twelve-month figure through Sep 2012 stood at $6.3 million (changed N/A YoY), and the FY2010 full-year result was $2.6 million, changed N/A from the prior year.
- Other financing activities declined to $1.3 million in Q3 2012 per CPHI's latest filing, from $5.0 million in the prior quarter.
- Across five years, Other financing activities topped out at $5.0 million in Q3 2011 and bottomed at $1.3 million in Q3 2012.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | China Pharma Holdings | 31.39 Mn | 31.08 Mn | 83,566.00 |